Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: A double-blind, placebo-controlled, clinical trial

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 7, 2000, Pages 711-718

  Casswall, T H ^a   Sarker, S A ^a   Faruque, S M ^a   Weintraub, A ^a   Albert, M J ^a   Fuchs, G J ^a   Alam, N H ^a   Dahlstrom, A K ^a   Link, H ^a   Brussow, H ^a   Hammarstrom, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bovine antibodies; Diarrhoea; Enteropathogenic Escherichia coli; Enterotoxigenic Escherichia coli; Escherichia coli; Infants and children; Oral therapy

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN;

ACUTE DIARRHEA; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CATTLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; MALE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033903954     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750023372     Document Type: Article

References (40)

1. Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh
2. Infectious agents causing watery diarrhoea in infants and young children in Bangladesh and their public health implications
3. Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: Epidemiology and pathogenesis
4. Escherichia coli that causes diarrhoea: Enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent
5. Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhoea and persistent diarrhoea syndrome
6. Epidemiology of traveler's diarrhea and relative importance of various pathogens
7. Diarrheagenic Escherichia coli
8. Elevation of intracellular free calcium levels in HEp-2 cells infected with enteropathogenic Escherichia coli
9. Intimin-dependent binding of enteropathogenic Escherichia coli to host cells triggers novel signaling events, including tyrosine phosphorylation of phospholipase C-γl
10. Colostral mononuclear phagocytes are able to kill Enteropathogenic Escherichia coli opsonized with colostral IgA
11. Bovine milk immunoglobulin for passive immunity to infantile rotavirus gastroenteritis
12. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants
13. Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, Shiga toxin-producing E-coli, and E-coli expressing intimin and hemolysin
14. Prevention of rotavirus infection by oral administration of cow colostrum containing antihuman rotavirus antibody
15. Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins
16. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli
17. Successful treatment of rotavirus diarrhoea in children with immunoglobulins from hyperimmune bovine colostrum: A randomised, double-blind, placebo-controlled trial
18. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum
19. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with Enterotoxigenic Escherichia coli
20. Field trial of an infant formula containing anti-rotavirus and anti-Escherichia coli milk antibodies from hyperimmunized cows
21. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: A double-blind, controlled clinical trial
22. Treatment of gastrointestinal infection in infants by oral administration of colostral antibodies
23. Controlled study of Escherichia coli diarrheal infections in Bangladeshi children
24. A comparative study of specific gene probes and standard bioassays to identify diarrhoeagenic Escherichia coli in paediatric patients with diarrhoea in Bangladesh
25. Salmonella sp. antibodies
26. Structural studies on the hexose region of the core in lipopolysaccharides from Enterobacteriaceae
27. Uber die extraction von bakterien mit phenol/wasser
28. Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh II. Incidence of diarrhea and association with known pathogens
29. Mucosal immunity and vaccination
30. Inhibition of enteropathogenic Escherichia coli adhesion to HEp-2 cells by colostrum and milk from mothers delivering low-birth weight neonates
31. Human colostrum contains IgA anti-bodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: Intimin, BfpA, EspA, and EspB
32. Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model
33. Enteropathogenic Escherichia coli diarrhea in hospitalized children in Bangladesh
34. Orally administered bovine colostral anti-cholera toxin antibodies: Results of two clinical trials
35. Analysis of the role of anti-lipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo
36. Molecular pathogenesis of enteropathogenic Escherichia coli
37. The digestion of colostral bovine immunoglobulins in infants
38. Survival of oral human serum globulin in the gastrointestinal tract of low birth weight infants
39. Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis
40. Human colostral IgA antibodies reacting to enteroparhogenic Escherichia coli antigen and their persistence in faeces of a breastfed infant